Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

844
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
844
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

3.8K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.8K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.7K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

677
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
677
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

1.1K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

REM Sleep-Associated Asystole.

JACC. Case reports·2026
Same author

Primary Total Knee Fixation Methods in Morbidly Obese Patients: Cemented, Stemmed, and Cementless Designs.

The Journal of arthroplasty·2025
Same author

The Path to a Match for Interventional Cardiology Fellowship: A Major SCAI Initiative.

Journal of the Society for Cardiovascular Angiography & Interventions·2024
Same author

Adopting Best Practices in the Management of Coronary Calcification.

Journal of the Society for Cardiovascular Angiography & Interventions·2024
Same author

Ossifying fasciitis of the proximal lower extremity.

Case reports in plastic surgery & hand surgery·2024
Same author

Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The National Cardiogenic Shock Initiative.

Journal of the American Heart Association·2023

Related Experiment Video

Updated: Mar 5, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

9.0K

Potential for Infra-Nodal Heart Block and Cardiogenic Shock With Propofol Administration.

Nicholas Olson1, Michael J Lim1, Scott W Ferreira1

  • 1Saint Louis University, Department of Cardiology, 3635 Vista Avenue, Saint Louis, MO, 63110-0250, 13th floor Desloge Tower, 63110-0250, USA.

Cardiology Research
|March 29, 2017
PubMed
Summary

Propofol can cause heart block, but this case shows a rare, sustained infra-nodal heart block. Prompt recognition and intervention, including pacing, are crucial for patient recovery.

Keywords:
AnesthesiaCardiogenic shockCardiomyopathyHeart blockHeart failureHypotensionImpellaLeft ventricular assist devicePropofolPropofol infusion syndrome

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

25.3K

Related Experiment Videos

Last Updated: Mar 5, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

9.0K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

25.3K

Area of Science:

  • Cardiology
  • Anesthesiology
  • Pharmacology

Background:

  • Propofol is a common anesthetic agent.
  • Transient bradycardia and heart block are known side effects of Propofol.
  • These effects are typically transient and related to the atrioventricular (AV) node.

Observation:

  • A previously healthy 64-year-old man developed infra-nodal complete heart block and cardiogenic shock.
  • This severe cardiac event occurred after receiving 180 mg of intravenous propofol.
  • The heart block was sustained and not transient.

Findings:

  • This case represents the first documented instance of sustained, complete infra-nodal heart block following propofol administration.
  • The mechanism appears to be distinct from the commonly observed transient, AV nodal effects.
  • The patient experienced cardiogenic shock secondary to the heart block.

Implications:

  • Early identification of sustained infra-nodal heart block is critical in patients receiving propofol.
  • Restoring atrio-ventricular (A-V) synchrony via dual-chamber pacing is essential.
  • Aggressive circulatory support is necessary to manage cardiogenic shock and facilitate recovery.